|
|
 Previous Article | Table of Contents | Next Article 
Indomethacin Is a Potent Inhibitor of Pristane and Plastic Disc Induced Plasmacytomagenesis in a Hypersusceptible BALB/c Congenic Strain
Michael Potter,
Judith Wax, and
Gary M. Jones
From Laboratory of Genetics, National Cancer Institute, National Institutes of Health, Bethesda; and PerImmune, Inc, Rockville, MD.
Continuous indomethacin (INDO) administration in the drinking water (10 to 20 µg/mL) profoundly inhibited plasmacytoma (PCT) development initiated by three 0.2- or 0.5-mL intraperitoneal (i.p.) injections of pristane in hypersusceptible BALB/c.DBA/2-Idh1-Pep3 congenic mice. The most effective inhibitions were obtained with continuous INDO treatment. When treatment was delayed until 50 to 60 days after the first pristane injection, there was approximately a 50% reduction in PCT incidence. The primary action of pristane is the induction of a chronic inflammation in the peritoneal connective tissues and the formation of a microenvironment where PCTs develop. INDO, a powerful inhibitor of prostaglandin synthases (cyclooxygenases 1 and 2), did not inhibit the formation of mesenteric oil granuloma nor the appearance of cells in this chronic inflammatory tissue carrying c-myc illegitimately joined to an Ig heavy chain switch region, ie, the t(12; 15) chromosomal translocation. INDO inhibited PCT induction by the i.p. implantation of 21 × 2 mm polycarbonate discs. These solid objects predominantly induce the formation of a patchy fibroplastic tissue on contacting peritoneal surfaces. These and previous data indicate that indomethacin inhibits an intermediate stage in PCT development after the arrival of cells bearing the T(12; 15) translocation in the oil granuloma and before these cells acquire transplantability to a pristane-conditioned host. The biological mechanism that explains how INDO inhibits PCT development is not yet established but appears to result from decreased production of prostaglandins in chronic inflammatory tissues (oil granuloma, fibroplasia), suggesting that prostaglandins play an active role in oil and solid plastic induced PCT formation.
Blood, Vol. 90 No. 1 (July 1), 1997:
pp. 260-269
© 1997 by The American Society of Hematology.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
S. Janz
Genetic and Environmental Cofactors of Myc Translocations in Plasma Cell Tumor Development in Mice
J Natl Cancer Inst Monographs,
July 1, 2008;
2008(39):
37 - 40.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. K. A. Mongini, J. K. Inman, H. Han, R. J. Fattah, S. B. Abramson, and M. Attur
APRIL and BAFF Promote Increased Viability of Replicating Human B2 Cells via Mechanism Involving Cyclooxygenase 2.
J. Immunol.,
June 1, 2006;
176(11):
6736 - 6751.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Sakiyama, K. Kondo, Y. Mitsuteru, H. Takizawa, K. Kenzaki, T. Miyoshi, M. Abe, S. Wakatsuki, and Y. Monden
Extramedullary plasmacytoma immunoglobulin D ({lambda}) in the chest wall and the subglottic region
J. Thorac. Cardiovasc. Surg.,
May 1, 2005;
129(5):
1168 - 1169.
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. Felix, S. Gerstmeier, A. Kyriakopoulos, O. M. Z. Howard, H.-F. Dong, M. Eckhaus, D. Behne, G. W. Bornkamm, and S. Janz
Selenium Deficiency Abrogates Inflammation-Dependent Plasma Cell Tumors in Mice
Cancer Res.,
April 15, 2004;
64(8):
2910 - 2917.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Padilla, K. Kaur, H. J. Cao, T. J. Smith, and R. P. Phipps
Peroxisome Proliferator Activator Receptor-{gamma} Agonists and 15-Deoxy-{Delta}12,1412,14-PGJ2 Induce Apoptosis in Normal and Malignant B-Lineage Cells
J. Immunol.,
December 15, 2000;
165(12):
6941 - 6948.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. Felix, K. A. Kelliher, G.-W. Bornkamm, and S. Janz
Elevated Mutant Frequencies in Lymphoid Tissues Persist throughout Plasmacytoma Development in BALB/c.{{lambda}}LIZ Mice
Cancer Res.,
August 1, 1999;
59(15):
3621 - 3626.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Potter, J. S. Wax, C. T. Hansen, and J. J. Kenny
BALB/c.CBA/N mice carrying the defective Btkxid gene are resistant to pristane-induced plasmacytomagenesis
Int. Immunol.,
July 1, 1999;
11(7):
1059 - 1064.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. R. Amoroso, N. Huang, A. B. Roberts, M. Potter, and J. J. Letterio
Consistent loss of functional transforming growth factor beta receptor expression in murine plasmacytomas
PNAS,
January 6, 1998;
95(1):
189 - 194.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. A. Mock, J. Hartley, P. Le Tissier, J. S. Wax, and M. Potter
The Plasmacytoma Resistance Gene, Pctr2, Delays the Onset of Tumorigenesis and Resides in the Telomeric Region of Chromosome 4
Blood,
November 15, 1997;
90(10):
4092 - 4098.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
